138 related articles for article (PubMed ID: 10501846)
1. Signaling defects in T lymphocytes of patients with malignancy.
Whiteside TL
Cancer Immunol Immunother; 1999 Oct; 48(7):346-52. PubMed ID: 10501846
[TBL] [Abstract][Full Text] [Related]
2. Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma.
Dworacki G; Meidenbauer N; Kuss I; Hoffmann TK; Gooding W; Lotze M; Whiteside TL
Clin Cancer Res; 2001 Mar; 7(3 Suppl):947s-957s. PubMed ID: 11300496
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer.
Kuss I; Saito T; Johnson JT; Whiteside TL
Clin Cancer Res; 1999 Feb; 5(2):329-34. PubMed ID: 10037182
[TBL] [Abstract][Full Text] [Related]
4. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer?
Whiteside TL
Cancer Immunol Immunother; 2004 Oct; 53(10):865-78. PubMed ID: 15118842
[TBL] [Abstract][Full Text] [Related]
6. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease.
Matsuda M; Petersson M; Lenkei R; Taupin JL; Magnusson I; Mellstedt H; Anderson P; Kiessling R
Int J Cancer; 1995 Jun; 61(6):765-72. PubMed ID: 7790109
[TBL] [Abstract][Full Text] [Related]
7. Immune cells in the tumor microenvironment. Mechanisms responsible for functional and signaling defects.
Whiteside TL
Adv Exp Med Biol; 1998; 451():167-71. PubMed ID: 10026868
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppression in renal cancer: differential expression of signal transduction molecules in tumor-infiltrating, near-tumor tissue, and peripheral blood lymphocytes.
Riccobon A; Gunelli R; Ridolfi R; De Paola F; Flamini E; Fiori M; Saltutti C; Petrini M; Fiammenghi L; Stefanelli M; Granato AM; Cuzzocrea DE; Amadori D
Cancer Invest; 2004; 22(6):871-7. PubMed ID: 15641485
[TBL] [Abstract][Full Text] [Related]
9. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.
Koyama S; Koike N; Adachi S
J Cancer Res Clin Oncol; 2002 Feb; 128(2):73-9. PubMed ID: 11862476
[TBL] [Abstract][Full Text] [Related]
10. Expression of TCR-zeta chain and apoptosis in subpopulations of tumor-associated lymphocytes (TALs) from malignant pleural effusions.
Sikora J; Zeromski J
Folia Histochem Cytobiol; 2002; 40(4):347-51. PubMed ID: 12502185
[TBL] [Abstract][Full Text] [Related]
11. Expression of TCR zeta chain of tumor associated lymphocytes from malignant pleural effusions.
Sikora J; Dworacki G; Zeromski J
Adv Exp Med Biol; 2001; 495():325-9. PubMed ID: 11774587
[No Abstract] [Full Text] [Related]
12. Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis.
Chen X; Woiciechowsky A; Raffegerst S; Schendel D; Kolb HJ; Roskrow M
Br J Haematol; 2000 Dec; 111(3):817-25. PubMed ID: 11122143
[TBL] [Abstract][Full Text] [Related]
13. Tumor-dependent down-regulation of the ζ-chain in T-cells is detectable in early breast cancer and correlates with immune cell function.
Boniface JD; Poschke I; Mao Y; Kiessling R
Int J Cancer; 2012 Jul; 131(1):129-39. PubMed ID: 21823123
[TBL] [Abstract][Full Text] [Related]
14. Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma.
Reichert TE; Day R; Wagner EM; Whiteside TL
Cancer Res; 1998 Dec; 58(23):5344-7. PubMed ID: 9850063
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib up-regulates the expression of the zeta chain of T cell receptor complex in tumor-infiltrating lymphocytes in human cervical cancer.
Ferrandina G; Ranelletti FO; Legge F; Salutari V; Martinelli E; Fattorossi A; Lorusso D; Zannoni G; Vellone V; Paglia A; Scambia G
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2055-60. PubMed ID: 16609015
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma.
Kowalczyk D; Skorupski W; Kwias Z; Nowak J
Br J Urol; 1997 Oct; 80(4):543-7. PubMed ID: 9352689
[TBL] [Abstract][Full Text] [Related]
17. CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs.
Agrawal S; Marquet J; Delfau-Larue MH; Copie-Bergman C; Jouault H; Reyes F; Bensussan A; Farcet JP
J Clin Invest; 1998 Nov; 102(9):1715-23. PubMed ID: 9802885
[TBL] [Abstract][Full Text] [Related]
18. [Expression of zeta (zeta) chain in peripheral blood T lymphocytes and NK cells of children with idiopathic nephrotic syndrome (INS)--preliminary results].
Musiał K; Ciszak L; Kosmaczewska A; Szteblich A; Pawlak E; Zwolińska D; Frydecka I
Przegl Lek; 2006; 63 Suppl 3():208-10. PubMed ID: 16898532
[TBL] [Abstract][Full Text] [Related]
19. Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix.
Santin AD; Bellone S; Palmieri M; Bossini B; Roman JJ; Cannon MJ; Bignotti E; Canè S; Pecorelli S
Gynecol Oncol; 2003 May; 89(2):271-80. PubMed ID: 12713991
[TBL] [Abstract][Full Text] [Related]
20. Expression of signal transducing T-cell receptor zeta molecules after adoptive immunotherapy in patients with gastric and colon cancer.
Kono K; Ichihara F; Iizuka H; Sekikawa T; Matsumoto Y
Int J Cancer; 1998 Oct; 78(3):301-5. PubMed ID: 9766562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
